advertisement
Advances in Therapy 22
Showing records 1 to 22 | Display all abstracts in Advances in Therapy76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative Glaucoma
Katsanos A
Advances in Therapy 2018; 35: 619-630
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Roberti G
Advances in Therapy 2018; 35: 686-696
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Myers JS; Masood I; Masood I
Advances in Therapy 2018; 35: 395-407
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative Glaucoma
Konstas AG
Advances in Therapy 2018; 35: 619-630
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Agnifili L; Berardo F
Advances in Therapy 2018; 35: 686-696
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative Glaucoma
Mikropoulos DG
Advances in Therapy 2018; 35: 619-630
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Hornbeak DM; Belda JI
Advances in Therapy 2018; 35: 395-407
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Riva I
Advances in Therapy 2018; 35: 686-696
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative Glaucoma
Quaranta L
Advances in Therapy 2018; 35: 619-630
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Auffarth G
Advances in Therapy 2018; 35: 395-407
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative Glaucoma
Voudouragkaki IC
Advances in Therapy 2018; 35: 619-630
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Figus M
Advances in Therapy 2018; 35: 686-696
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative Glaucoma
Athanasopoulos GP
Advances in Therapy 2018; 35: 619-630
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Manni G
Advances in Therapy 2018; 35: 686-696
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative Glaucoma
Athanasopoulos GP
Advances in Therapy 2018; 35: 619-630
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Jünemann A
Advances in Therapy 2018; 35: 395-407
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Quaranta L
Advances in Therapy 2018; 35: 686-696
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Giamporcaro JE
Advances in Therapy 2018; 35: 395-407
76912 A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative Glaucoma
Asproudis I; Teus MA
Advances in Therapy 2018; 35: 619-630
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Martinez-de-la-Casa JM
Advances in Therapy 2018; 35: 395-407
76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Oddone F
Advances in Therapy 2018; 35: 686-696
76564 Prospective Evaluation of Two iStent Trabecular Stents, One iStent Supra Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
Ahmed IIK; Voskanyan L; Katz LJ
Advances in Therapy 2018; 35: 395-407
